Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000174 per share
-
Shares outstanding
-
55,803,824
-
Total 13F shares
-
17,687,819
-
Share change
-
+742,934
-
Total reported value
-
$53,391,000
-
Price per share
-
$3.02
-
Number of holders
-
26
-
Value change
-
-$622,344
-
Number of buys
-
20
-
Number of sells
-
13
Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB) as of Q1 2022
As of 31 Mar 2022,
Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,687,819 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., FMR LLC, BlackRock Inc., JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Ikarian Capital, LLC, Sio Capital Management, LLC, RTW INVESTMENTS, LP, BARCLAYS PLC, and BANK OF AMERICA CORP /DE/.
This page lists
26
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.